The market share of plant-derived drugs and treatments is growing at a fast pace.
This is according to data from Grand View Research, with sales of this booming segment of the pharmaceutical industry finishing 2019 at $131.5 billion.
Moving forward, data from GVR’s study indicates that the market should continue to grow at a compounded annual growth rate of 7% and companies like Cannabotech are spearheading this expansion by introducing a wide range of cannabis-based products including cannabidiol (CBD) products.